Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
1(25.0%)
Early Phase 1
1(25.0%)
4Total
N/A(2)
Phase 1(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03178981Not ApplicableCompleted

E-cigarette Nicotine Pharmacokinetic Study

Role: collaborator

NCT02792426Phase 1Completed

Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users

Role: collaborator

NCT02474849Early Phase 1Completed

Pharmacokinetic Study Comparing Nicotine Delivery From E-cigarettes and a Conventional Cigarette in Healthy Subjects

Role: collaborator

NCT01898169Not ApplicableUnknown

Evaluation of Short-term Safety and Use Patterns of an Electronic Nicotine Delivery System

Role: lead

All 4 trials loaded